Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;114:e628
doi: 10.1161/CIRCULATIONAHA.106.665018
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kulik, A.
Right arrow Articles by Burwash, I. G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kulik, A.
Right arrow Articles by Burwash, I. G.
Related Collections
Right arrow Valvular heart disease
Right arrow CV surgery: valvular disease

(Circulation. 2006;114:e628.)
© 2006 American Heart Association, Inc.


Correspondence

Response to Letter Regarding Article, "Long-Term Outcomes After Valve Replacement for Low-Gradient Aortic Stenosis: Impact of Prosthesis-Patient Mismatch"

Alexander Kulik, MD; Varun Kapila, MD; Thierry G. Mesana, MD, PhD; Marc Ruel, MD, MPH

Division of Cardiac Surgery, University of Ottawa Heart Institute, Ottawa, Canada

Ian G. Burwash, MD

Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Canada


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

We thank Bleiziffer and colleagues for their interest and insightful comments regarding our article1 describing long-term outcomes after valve replacement for patients with low-gradient aortic stenosis. In our analyses, prosthesis-patient mismatch (PPM) was characterized as an indexed effective orifice area (EOA) of ≤0.85 cm2/m2 because this definition constitutes the most generally accepted criterion for PPM.2 As Bleiziffer et al note in their letter, the use of geometric internal orifice area as a measure of prosthesis size is limited and does not effectively predict hemodynamic or clinical outcomes. We did not use geometric orifice area in our analyses because geometric orifice area does not account for many valve characteristics that contribute to the EOA, such as prosthesis height, profile, opening angle, and leaflet inertia.

We agree with Bleiziffer and colleagues that the EOA derived by Doppler echo continuity equation from individual patients after implantation of the prosthesis may have better quantified the degree of PPM in our study of low-gradient aortic stenosis patients. This methodology has several important limitations, however, related to the difficulties caused by prosthetic valve reverberations in accurately measuring left ventricular outflow diameter after surgery. Moreover, the presence of large localized transprosthetic gradients or nonuniform transprosthetic spatial velocity profiles frequently result in large discrepancies between Doppler echo and actual EOA measurements.3,4 Therefore, we used fixed values of in vivo EOAs (also known as projected EOAs) for each prosthesis type and size from literature sources of patients with normally functioning prostheses.2 Projected EOA values can be attributed to . . . [Full Text of this Article]